Related Experiment Video
Updated: Jan 30, 2026

Screening of Tobacco Genotypes for Phytophthora nicotianae Resistance
Published on: April 15, 2022
Tobacco Cessation Services in Addiction Treatment: What Do Clients Say?
Joseph Guydish1, Deborah Yip1, Thao Le1
1Philip R. Lee Institute for Health Policy Studies, University of California, San Francisco, San Francisco (UCSF) (Guydish, Yip, Le, Gubner, Williams); Department of Psychiatry, UCSF (Delucchi).
Objective:
Specialty addiction programs treat people who are addicted to alcohol, opioids, stimulants, and other drugs. This study identified the proportion of addiction program clients who received tobacco-related services and factors associated with receipt of such services.
Methods:
In 2015 and 2016, clients (N=2,119) in 24 programs were surveyed for receipt of services aligning with three of the five As of tobacco cessation: ask, advise, assist. Multivariate analyses examined factors associated with receipt of each service.
Results:
Most clients (76%) were asked about smoking. Among smokers (N=1,630), 53% were advised to quit, 41% received counseling, 26% received cessation medication, and 17% received counseling and medication. Clients were more likely to receive tobacco-related services if they wanted help quitting smoking or were enrolled in programs with tobacco-free grounds.
Conclusions:
These correlational findings suggest that increasing client motivation to quit and implementing tobacco-free policies on the grounds of treatment centers may increase tobacco-related services in addiction treatment.
More Related Videos
Related Concept Videos
Drug Abuse and Addiction: Pharmacological Phenomena
Primary Healthcare Services
In 1978, international leaders convened in Alma-Ata, Kazakhstan, for what would be a pivotal event in global health. The Alma-Ata Declaration was the first to call...
Preventive Healthcare Services
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Treatment Resistant Cancers
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...

